There is currently no standardized definition of what constitutes focal therapy in terms of number of foci ablated, whether unilateral or bilateral disease is included and what amount of tissue should ...

Salvage focal therapy may offer durable localized prostate cancer control for up to 10 years compared with salvage radical prostatectomy for radiorecurrent disease. For patients with localized, biopsy ...

A minimally invasive targeted treatment called salvage focal therapy, which targets just the cancerous area of the prostate, can treat men whose prostate cancer has recurred after radiotherapy with ...

In a retrospective study of patients from high-volume centers undergoing salvage RARP after failure of primary prostate cancer therapy, only 1% overall experienced intraoperative complications.

Salvage focal therapy and radical prostatectomy are both effective in treating localized radiorecurrent prostate cancer, a cohort study suggested. There were no statistically significant differences ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...

Anant Madabhushi,, the F. Alex Nason Professor II of Biomedical Engineering and director of the Center for Computational Imaging and Personalized Diagnostics, was part of the Engineering and Imaging ...

High-intensity focused ultrasound (HIFU) is a noninvasive way to destroy tissue or stop it from working. It was approved by the U.S. Food and Drug Administration for prostate ablation in 2015, but the ...

UCH/UCL NIHR Comprehensive Biomedical Research Centre, London, UK. Tel.: +44 207 380 9194, Fax: +44 207 380 9303, markemberton1@btinternet.com Focal therapy is an emerging research area that aims to ...